At 24 h after birth, the levels of IL-6 and TNF-α are both increased in children who received ROP treatment, while the concentration of IL-6 is negatively correlated with IGF-1 between 5–8 weeks after birth (55). This evidence concerns the gene IGF1 and retinopathy of prematurity.